Ondine Biomedical Inc. (AIM: OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 10.83
-0.17 (-1.55%)
Jan 22, 2025, 8:12 AM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 44.70 million as of January 22, 2025. Its market cap has increased by 113.10% in one year.
Market Cap
44.70M
Enterprise Value
44.20M
Revenue
944.68K
Ranking
n/a
PE Ratio
n/a
Stock Price
10.83
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 44.70M, a decrease of -60.40%. That is a compound annual growth rate of -25.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 44.70M | 25.71% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.25B |
| Haleon | 33.25B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.68B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |